£67.65

Biomarkers for Early Diagnosis of Alzheimer's Disease

Neurology & Clinical Neurophysiology

Price data last checked 45 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 46 days • 46 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 46 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £68 (32 days, 69.6%)

Price range: £66 - £68

Price levels: 2 different prices over 46 days

Description

Alzheimer's disease (AD) is characterized by the deposition into the brain of amyloid peptide, which originates a cascade of inflammatory events leading eventually to neuronal death. These pathological events likely occur several years before the clinical manifestation of the disease, implying that potential therapeutical interventions are currently started too late to give beneficial results. Recently, growing attention has been paid to the Mild Cognitive Impairment (MCI), considered the prodromal phase of AD, as 80% of subjects with MCI have been shown to develop AD within 5 years. Several studies aimed to identify biological markers to differentiate between normal aging and incipient AD have been carried out, including cerebrospinal fluid (CSF) analysis and neuroimaging. In particular, the evaluation of CSF Amyloid beta (1-42) levels, together with tau and phospotau, are of help for recognizing early AD. Besides, a number of additional molecules are altered in CSF. Other early modifications have been observed in peripheral cells, such as fibroblasts and leukocytes, as well as in serum from patients. Biomarkers for AD represent important tools supporting the clinical diagnosis and the choice of potential therapeutic options. Moreover, they would be of great help for the selection of cohorts of homogeneous patients for clinical trials with new disease-modifying compounds. This book is aimed to give an update about MCI as prodromal Alzheimer's disease (AD), to discuss the main known pathological mechanisms at the basis of AD and to describe the possible biomarkers to be used for an early diagnosis of the disease.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format: hardcover
ASIN: 1604569913
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 01 December 2008
Listed Since: 19 July 2010

Barcode

No barcode data available

Biomarkers for Early Diagnosis of Alzheimer's Disease

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Alzheimer's Diagnosis (Neuroscience Research Progress)

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry, 38)

Progressive Cognitive Impairment & its Neuropathologic Correlates

Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2

Molecular Pathology of Alzheimer's Disease (Colloquium Series on Neurobiology of Alzheimer's Disease)

Neuroprotection in Alzheimer's Disease

Current Hypotheses and Research Milestones in Alzheimer's Disease

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)

Alzheimer's Disease in the Middle-Aged

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Smart Diagnostics for Neurodegenerative Disorders: Neuro-sensors

Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)

Multiparametric Imaging in Neurodegenerative Disease (Neuroscience Research Progress)

Pathobiology of Alzheimer's Disease (Neuroscience Perspectives)

Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)